Global Business NewsGlobal Business News
In-person information sessions hosted in GBA and SEA HONG KONG, April 6, 2023 /PRNewswire/ -- Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2023 Global Pitch Competition ("JUMPSTARTER 2023") is now open for application, inviting entries from start-ups worldwide to bring more like-minded organizations together to bolster the growth of innovation and technology globally. Due to the easing of COVID-19 restrictions, JUMPSTARTER 2023 will again host a series of in-person information sessions, including cities in the Greater Bay Area including Hong Kong, Shenzhen, Guangzhou and Zhuhai, as well as Southeast Asia including Singapore and Vietnam. To encourage more talents and drive the development of innovation in the region, successful entrepreneurs and industry experts will be invited to share their entrepreneurial journeys and challenges as well as to examine the current business climate and growth prospects in the market. So far, the information sessions attracted nearly 1,000 start-ups or those interested in JUMPSTARTER. Cindy Chow, Executive Director of Alibaba Hong Kong Entrepreneurs Fund (left), said, "During the height of COVID-19, we were incredibly inspired to see many start-ups unlock innovative ways to address societal pain points. We want to encourage start-ups in the sixth JUMPSTARTER to address the Sustainable Development Goals of the United Nations. We have added biotech, industry 4.0 and web 3.0 to capture the emerging market trends. JUMPSTARTER aspires to be a platform that supports individuals with entrepreneurial aspirations to accelerate the innovation and technology industry with our partners." Frank Fang, General Manager, Head of Commercial Banking, Hong Kong and Macau, HSBC (right), said, "We are pleased to partner with Alibaba Entrepreneurs Fund for the fifth consecutive year in the JUMPSTARTER Global Pitch Competition, unlocking the potential of promising start-ups around the world. Innovation has emerged as an engine for high-quality and sustainable growth globally. In Hong Kong, our rapid transformation into an international innovation hub and increasing integration with other cities in the Greater Bay Area offer a fertile breeding ground to international start-ups. As a long-term partner of the business community, HSBC will continue to leverage our international network and financing expertise to support high-growth companies and play to our strengths as a super-connector in the start-up ecosystem." JUMPSTARTER 2023 Information session held in Hong Kong During the information session in Hong Kong on March 31, 2023, a panel discussion was hosted by Jason Chen, Chief Operating Officer and Managing Director of Gobi Partners, to explore "Riding the AI wave: How start-ups and Venture Capitalists are navigating the Future of AI", attended by Patrick Tu, Co-Founder & CEO of Dayta AI; Ivan Lau, Co-Founder & CEO of Pantheon Lab Limited; Miles Wen, Co-Founder & CEO of Fano Labs Limited; and Tim Lee, Partner of Creo Capital. JUMPSTARTER 2023 Information Session in Singapore During the information session in Singapore on April 3, 2023, a panel discussion was hosted by Olive Tai, Co-founder & Managing Director of Synagie, to explore "Breaking Borders: How Hong Kong and the Greater Bay Area are unlocking opportunities for Southeast Asia starts", attended by Atul Babu, Founder & CEO of Dhata Tech; Vincent Chow, Founder & CEO of En-trak (JUMPSTARTER 2017 Winner); and Ivan Goh, CEO of QuantumTX (JUMPSTARTER 2022 Top 10). Ivan Goh, CEO of QuantumTX said, "Participating in start-up competitions can offer numerous benefits and opportunities beyond winning a prize. JUMPSTARTER has given QuantumTX a good chance to grow engagement with the Hong Kong and Mainland China market. As a finalist, we were given the exhibition space to present our technology in Hong Kong. With that, QuantumTX gained more credibility that aroused interest in Hong Kong and the GBA. Last year, QuantumTX's business in Hong Kong and the Greater Bay Area (GBA) grew considerably, making up about 20% to 30% of their top-line." Vincent Chow, Founder & CEO of En-trak said, "Starting a start-up can be a daunting challenge, especially when you do not have an established brand, network or financial backing. Therefore, participating in respected start-up competitions like JUMPSTARTER can be a good starting point to gain credibility and recognition from potential customers. Winning over your first corporate client can ignite a ripple effect, rapidly accelerating the growth of your customer base." JUMPSTARTER 2023 information session held in Shenzhen During the information session in Shenzhen on March 28, 2023, a panel discussion was hosted by Bohan Zheng, Senior Investment Manager of Gobi Partners, to explore "How to Leverage Hong Kong to Seize the Opportunities of Globalization", attended by Johnny Tang, Chief Operation Officer of Qupital; Yu Tian, Founder and CEO of Shenzhen Smart Supply Chain; and Zhang Shuai, Founder of HALOBLK. Johnny Tang, COO of Qupital said, "Hong Kong's advanced financial system offers extensive support and collaboration opportunities for startups, while also providing reliable measures for corporate financing. As a fintech startup, Qupital's success greatly depends on the exceptional support of our Hong Kong team in finance and risk management, empowering businesses to achieve a stable and sustainable growth." Zhang Shuai, Founder of HALOBLK said, "Hong Kong offers an expansive platform for global capital, providing startups with abundant prospects for growth and resources. With Hong Kong's rich background in foreign trade, startups can capitalize on this advantage to export their products to international markets, reach new heights in overseas expansion, attract diverse talent from round the world, customize their products to local markets, and achieve accelerated development." JUMPSTARTER 2023 is now open for application. Please visit https://www.jumpstarter.hk/en/ for more details. About Alibaba Hong Kong Entrepreneurs Fund Alibaba Hong Kong Entrepreneurs Fund ("AEF") is a not-for-profit initiative launched by Alibaba Group in 2015. To vitalize the development of innovation and technology, AEF's mission is to help Hong Kong entrepreneurs and young people realize their dreams and visions for a Hong Kong that is vibrant and engaged regionally and globally. As part of its investment program, AEF provides Hong Kong-based entrepreneurs with investment capital and strategic guidance to help them grow their businesses and penetrate the mainland Chinese and global markets, by utilizing Alibaba's Ecosystem. For more information, please visit the website: https://www.ent-fund.org/en/ About JUMPSTARTER JUMPSTARTER is a not-for-profit initiative created by Alibaba Hong Kong Entrepreneurs Fund that provides a platform for all entrepreneurs and young people to jump start their dreams in Hong Kong. It is a first-of-its-kind start-up event focused exclusively on showcasing quality start-ups and providing high-impact networking opportunities. Its goal is to build, empower and boost Hong Kong's start-up ecosystem and entrepreneurship by bringing entrepreneurs, corporations, investors and the public together, helping to transform Hong Kong into a leading hub for global innovation and technology. For more information, please visit the website: https://www.jumpstarter.hk/en/
Obtained ISO 37001 from Korea Compliance Initiative (KCI) To practice ESG management by enhancing management transparency and ethical management YONGIN, South Korea, April 6, 2023 /PRNewswire/ -- GC Cell (KOSDAQ: 144510), a Korean biotech company, announced on Apr. 6th that it has successfully attained the international certification for the anti-bribery management system, ISO 37001, from Korea Compliance Initiative (KCI), an international certification body. ISO 37001 is the international standard for meeting global anti-bribery efforts, such as the OECD Anti-bribery Convention and the UN Convention against Corruption. It defines the control and prevention guidelines against corruption risks that may arise in any organization. The International Organization of Standardization issues it based on a rigorous assessment of whether an organization's management system complies with the international standards for anti-corruption. With the accreditation by ISO 37001, GC Cell is now equipped with control measures for detecting corruption risks as well as a system to prevent corruption and misconduct. The company plans to continue strengthening employee training on the anti-bribery management system and ensuring strict compliance with relevant laws and regulations so that all employees internalize ethical and compliant practices as they perform everyday work. "We will practice ESG management by enhancing management transparency and further strengthening ethical management so that GC Cell can fulfill its social role and responsibilities." said James Park, CEO of CG Cell. About GC Cell GC Cell is an integrated corporation created through the recent merger of Green Cross Labcell and Green Cross Cell and focuses on the development and production of treatments using immune cells and stem cells. In particular, it has a variety of pipelines for autologous and allogeneic cell therapies. It also has global competitiveness based on platform technology and experience throughout the entire period from the initial research stage to the commercialization stage.
SINGAPORE, April 6, 2023 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") a leading manufacturer and distributor of engines for on- and off-road applications in China through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited ("GYMCL"), wishes to announce that GYMCL has incorporated a wholly-owned subsidiary, Guangxi Xing Yun Cloud Technology Co., Ltd., ("Xing Yun Cloud") with a registered capital of RMB 10 million. This newly formed subsidiary will develop proprietary operating systems to enable data analytics for smart and connected solutions for both on- and off-road vehicles as well as machineries. In addition, Xing Yun Cloud will manage IT operations and maintenance, develop and support new digital projects, and develop intelligent networks and processes for the GYMCL group of companies. About China Yuchai International China Yuchai International Limited, through its subsidiary, Guangxi Yuchai Machinery Company Limited ("GYMCL"), engages in the manufacture, assembly, and sale of a wide variety of light-, medium- and heavy-duty engines for trucks, buses, passenger vehicles, construction equipment, marine and agriculture applications in China. GYMCL also produces diesel power generators. The engines produced by GYMCL range from diesel to natural gas and hybrid engines. Through its regional sales offices and authorized customer service centers, GYMCL distributes its engines directly to auto OEMs and retailers and provides maintenance and retrofitting services throughout China. Founded in 1951, GYMCL has established a reputable brand name, strong research and development team and significant market share in China with high-quality products and reliable after-sales support. In 2022, GYMCL sold 321,256 engines and is recognized as a leading manufacturer and distributor of engines in China. For more information, please visit http://www.cyilimited.com. Safe Harbor Statement: This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe", "expect", "anticipate", "project", "targets", "optimistic", "confident that", "continue to", "predict", "intend", "aim", "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that may be deemed forward-looking statements. These forward-looking statements including, but not limited to, statements concerning China Yuchai's and the joint venture's operations, financial performance and condition are based on current expectations, beliefs and assumptions which are subject to change at any time. China Yuchai cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors such as government and stock exchange regulations, competition, political, economic and social conditions around the world and in China including those discussed in China Yuchai's Form 20-Fs under the headings "Risk Factors", "Results of Operations" and "Business Overview" and other reports filed with the Securities and Exchange Commission from time to time. Among others, if the COVID-19 pandemic is not effectively and timely controlled, our business operations and financial condition may be materially and adversely affected due to a deteriorating market for automotive sales, an economic slowdown in China and abroad, a potential weakening of the financial condition of our customers, or other factors that we cannot foresee. All forward-looking statements are applicable only as of the date it is made and China Yuchai specifically disclaims any obligation to maintain or update the forward-looking information, whether of the nature contained in this release or otherwise, in the future. For more information: Investor RelationsKevin TheissTel: +1-212-510-8922Email: firstname.lastname@example.org
BEIJING, April 6, 2023 /PRNewswire/ -- A report from CRIOnline: The 20th China-ASEAN Expo Overseas Exhibition is held in Singapore. (photo by Huang Ke) The 20th CAEXPO Roadshow in Singapore ended successfully on the afternoon of April 5th. The roadshow was attended by about 80 companies from Guangxi as well as more than 400 professional Singapore buyers. The ratio of exhibitors to purchasers invited exceeded 1:5. Wuzhou Liubao tea, Hengzhou jasmine tea, Guangxi specialty fruits, prepared vegetables, golf carts and sightseeing cars are among the most popular products, and many companies have received orders. For example, during the roadshow, Guangxi Qiaowang Pulp Packing Products had a face-to-face business negotiation with Duni, a European customer headquartered in Sweden with its Asia-Pacific office set up in Singapore, and has received a new sales order of 3 million yuan this year. According to reports, at an industry trade symposium held the previous afternoon during the roadshow, 49 exhibitors from agricultural products and food, new energy products, legal and medical services, project investment and other fields had on-site exchanges and negotiations with more than 200 buyers. Lee Yi Shyan, chairman of Singapore's Business China, said that due to the lack of physical exchanges in the past few years, Guangxi products are now entering the Singapore market will help local companies strengthen trade and investment cooperation with Guangxi. As of April 5th, the exhibition has reached a cooperation intention amount of $145.8649 million, including $124.2161 million for procurement, $14.5348 million for investment, and $7.114 million for service trade.
BAODING, China, April 6, 2023 /PRNewswire/ -- On March 30, GWM released its 2022 annual report. In 2022, the total operating revenue of GWM was 137.34 billion CNY. The net profit attributable to shareholders of listed companies was 8.27 billion CNY, a year-on-year increase of 22.90%. GWM 2022 Annual Performance Report: 12.18 billion CNY R&D investment, up 34% In 2022, GWM maintained a healthy and sustainable financial situation by accelerating the pace of intelligent and new energy transformation, releasing product potential and market momentum. And it has made progress in new energy, intelligence, globalization, and system transformation. In 2023, the company will continue to take technology development as the foundation, take global development as the wing, adhere to the new energy declaration of "Greener, Higher, Safer", let conscientiousness and honesty be the essence of car-making, let core technology lead as the essence of competition, and let technology realize equal rights for all people. Under the background of the intelligent and the new energy revolution in the industry, GWM continued to strengthen scientific and technological innovation. In 2022, the company invested 12.18 billion CNY in research and development, a year-on-year increase of 34.34%, accounting for 8.87% of the total operating revenue. It continued to strengthen research and development capabilities, consolidate its foundation with technological innovation, and further enhance its core competitiveness. As the only automotive company in China and the only one of two in the world that has completed a flat, networked, and decentralized layout of the entire industrial chain in the two major fields of energy and intelligence, GWM has established a forest ecosystem with multiple species interacting and continuously evolving, forming a complete industrial layout, achieving independent control of core technologies and efficient collaboration of organizational systems. In the field of new energy, GWM has established a parallel development strategy of hybrid, pure electric, and hydrogen energy, with multiple technological routes. It has built an industry-leading energy system of "photovoltaic + distributed energy storage + centralized energy storage", and completed the entire value chain layout of "solar energy - battery - hydrogen energy - vehicle power". The recently released new intelligent four-wheel drive hybrid technology Hi4 has achieved a "new configuration" of three power sources with dual axis distribution, a "new breakthrough" in iTVC intelligent torque vector control system, and a "new height" in electromechanical coupling transmission systems. This technology will be first applied on the newly launched HAVAL new energy model, and the full range of new energy products from GWM will also be fully popularized in 4WD by 2024. In the future, in the face of increasingly fierce market competition, GWM forest ecosystem will continue to exert its strength, comprehensively deploy intelligent new energy fields with new sequences, new channels, new models, new technologies, and new products, to continuously improve its product mix and meet the diverse needs of consumers.
The Malaysia Healthcare Travel Council: Upholding Medical Innovations as a Cancer Care Centre of Excellence
Malaysian health practitioners are at the helm of various new techniques to treat tongue, blood and orthopaedic-related cancers in their race to boost cancer care accessibility.KUALA LUMPUR, MALAYSIA - Media OutReach - 6 April 2023 - Cancer has become a leading cause of premature death, with nearly 10 million lives being lost to the disease in 2020. As the world celebrates the 2023 World Health Day with the theme Health for All, it is worth noting that healthcare practitioners are keeping pace with technological advances, which are increasingly opening up access to state-of-the-art treatments in oncology. In 2020, researchers at Universiti Sains Malaysia (USM) in Malaysia devised a groundbreaking treatment for tongue cancer. Spearheaded by Dr. Gokula Kumar Appalanaido, a Visiting Consultant Radiation Oncologist at the Penang Adventist Hospital, the technique proved successful, with two patients recovering within six months of clinical trials. Known as Hybrid Brachytherapy Intensity Modulated Radiation Therapy (HyBIRT), brachytherapy needles are applied directly into the tumour, followed by further radiotherapy and chemotherapy. "Oncology has advanced by leaps and bounds. It's amazing how tumours can now be removed without surgery," said Dr. Gokula. Underpinned by a professional training system, Malaysia benefits from a wealth of medical expertise, which is also behind a variety of oncology innovations. "For our part, allogeneic bone marrow transplants are now possible, even from donors who are only partially compatible genetically," said Dr. Ng Soo Chin, a consultant haematologist at the Subang Jaya Medical Centre. Introduced to treat various blood cancers, including leukaemia, the method is found to reduce the risk of cancer recurrence by up to 22%, as grafts from allogeneic transplants are free from contaminant cells,. "This allows for a potentially enlarged pool of donors, like distant relatives, and what's more, it's almost as effective as a fully-matched transplant," continued Dr. Ng. While surgeries sometimes cannot be avoided, numerous techniques have been developed through the years to facilitate better outcomes. One of these is limb-salvage surgery. It involves the targeted removal of a tumour without affecting the rest of the limb, thus negating the need for amputations in cases of orthopaedic-related cancer. According to researchers at USM, the survival rate for osteosarcoma patients who underwent limb-salvage surgery stood at 85% at two years, which is significantly greater than for amputees. "We can now remove big portions of a bone or tissue, after which the defect is reconstructed, sometimes using donor cells," added Dr Prashant Narhari, a Visiting Consultant Orthopaedic, Traumatologist and Oncologist at the Penang Adventist Hospital. As medical technology progresses, oncology treatments are evolving in tandem, with healthcare practitioners racing to enhance cancer care access for all. The growing availability of various cancer treatments in Malaysia is a step forward that aligns with this year's World Health Day's call for Health for All, becoming a testament to the shared commitment to improving patient outcomes within the country. Find out more about Malaysia's oncology offerings at https://www.youtube.com/watch?v=zP9MZ35Xfv0. For more information on Malaysia Healthcare and its services, please visit https://malaysiahealthcare.org.my or visit our social feeds at: www.facebook.com/MHTCMalaysia or at LinkedIn (Malaysia Healthcare Travel Council).  https://www.who.int/news-room/fact-sheets/detail/cancer  https://news.usm.my/index.php/english-news/6592-hybirt-usm-develops-new-pioneering-technique-in-treating-tongue-cancer  https://www.ncbi.nlm.nih.gov/books/NBK12844/  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697888/  https://msprs.org.my/wp-content/uploads/2018/06/2015-Osteosarcoma-HUSM.pdf Hashtag: #MalaysiaHealthcare The issuer is solely responsible for the content of this announcement.About The Malaysia Healthcare Travel Council The Malaysia Healthcare Travel Council (MHTC) is a government agency under the Ministry of Health Malaysia that has been entrusted with the responsibility of curating the country's healthcare travel scene. Founded in 2009, MHTC works to streamline industry players and service providers in facilitating and growing Malaysia's healthcare travel industry under the brand "Malaysia Healthcare" with the intended goal of making Malaysia the leading global healthcare destination. MHTC works closely with over 80 private healthcare facilities in Malaysia, who are registered members of MHTC.